Achim Schäffler
Corporate Officer/Principal at Horizon Therapeutics GmbH
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gabriele Eismann | M | 62 | 33 years | |
| Dietmar Oeter | M | 57 | 29 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Olaf Klinger | M | 59 | 4 years | |
| Rainer Lichtenberger | M | 65 | 14 years | |
| Matthew Emmens | M | 72 | 4 years | |
| Veit Ulshöfer | M | 61 | 23 years | |
| Ralf Eisenhauer | M | 55 |
Ruprecht-Karls-Universität Heidelberg
| 6 years |
| Carsten Evers | M | 60 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 5 years |
| Karl Härfstrand | M | 66 |
Horizon Therapeutics Switzerland GmbH
 Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | 3 years |
| Daniela Birkenfeld | M | 64 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 5 years |
| Valentin Chapero Rueda | M | 68 |
Ruprecht-Karls-Universität Heidelberg
| 3 years |
| Michael G. Hoesch | M | 65 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 4 years |
| Rick Ryan | M | - | 11 years | |
| Jochen Mattis | M | - |
Horizon Therapeutics Switzerland GmbH
Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | 6 years |
| Michael-Dragos Anastasiu | M | 59 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 4 years |
| Michael Odenwald | M | 66 |
Ruprecht-Karls-Universität Heidelberg
| 3 years |
| Ina Schlie | F | 57 |
Ruprecht-Karls-Universität Heidelberg
| 5 years |
| Hartmut Tintrup | M | - |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 3 years |
| Nigel Williams | M | - | 11 years | |
| Uta Kemmerich-Keil | F | 58 | 19 years | |
| Yi Zhun Zhu | M | 58 |
Ruprecht-Karls-Universität Heidelberg
| 3 years |
| Michael Albrecht | M | 74 |
Ruprecht-Karls-Universität Heidelberg
| 5 years |
| Uwe Nickel | M | 66 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 3 years |
| Marc Hambach | M | - |
Ruprecht-Karls-Universität Heidelberg
| 6 years |
| Christine Hohmann-Dennhardt | M | 74 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| - |
| Hans-Peter Fischer | M | 64 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 3 years |
| Daniel Cravo | M | - | - | |
| Pascale Fouqueray-Grellier | M | 61 | - | |
| Sophie Hallakou-Bozec | M | - | - | |
| Thomas Kuhn | M | 50 | - | |
| Hans-Sebastian Graf von Wallwitz | M | 59 |
Ruprecht-Karls-Universität Heidelberg
| 4 years |
| Christopher Delbrück | M | 57 |
Ruprecht-Karls-Universität Heidelberg
| 4 years |
| Eva Wimmers | F | 55 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 4 years |
| Andreas Hoffmann | M | 60 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 3 years |
| Heiner Pieper | M | - | - | |
| Helmut Hufnagel | M | - |
Ruprecht-Karls-Universität Heidelberg
| 3 years |
| Lynne Sullivan | F | 58 | 8 years | |
| Malte Peters | M | 61 | 1 years | |
| Christophe Couturier | M | 58 | 12 years | |
| Ulrich Kipper | M | 64 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 4 years |
| Patricia Geibel-Conrad | F | 62 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 4 years |
| Michael Christian Knorz | M | 65 |
Ruprecht-Karls-Universität Heidelberg
| 10 years |
| Markus Ziener | M | 58 |
Ruprecht-Karls-Universität Heidelberg
| 4 years |
| Rajkumar Kannan | M | 61 | 9 years | |
| Jörg Hornstein | M | 47 | 11 years | |
| Peter Nagler | M | - |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 4 years |
| Thomas Carell | M | 58 |
Ruprecht-Karls-Universität Heidelberg
| 3 years |
| Heiko Carrie | M | - |
Ruprecht-Karls-Universität Heidelberg
| 3 years |
| Frank-Peter Kaufmann | M | 76 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 11 years |
| Simone Faath | F | 58 |
Ruprecht-Karls-Universität Heidelberg
| 1 years |
| Benita Gräfin von der Schulenburg | F | - |
Ruprecht-Karls-Universität Heidelberg
| 4 years |
| Felix Kratz | M | - |
Ruprecht-Karls-Universität Heidelberg
| 4 years |
| Thomas Lander | M | 71 | - | |
| Mechthild Auge | M | 66 | 18 years | |
| Rolf Wiswesser | M | - |
Ruprecht-Karls-Universität Heidelberg
| 5 years |
| Wolfgang Herrmann | M | 76 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 3 years |
| Youming Zhang | M | 60 |
Ruprecht-Karls-Universität Heidelberg
| 3 years |
| Hubert Birner | M | 57 |
Horizon Therapeutics Switzerland GmbH
Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | 2 years |
| Regina Hodits | M | 53 |
Horizon Therapeutics Switzerland GmbH
Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | - |
| Elmar Schnee | M | 65 | 8 years | |
| Sven Weber | M | 54 |
Ruprecht-Karls-Universität Heidelberg
| 5 years |
| Ernst-Moritz Lipp | M | 73 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| - |
| Hans-Joachim Langmann | M | - | 39 years | |
| Peter Johann | M | 67 |
Horizon Therapeutics Switzerland GmbH
Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | - |
| Hans-Joachim Lohrisch | M | 75 | 21 years | |
| Gabriele Fontane | M | 59 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 5 years |
| Peter H. Reinisch | M | 84 |
Horizon Therapeutics Switzerland GmbH
Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | - |
| John Pohlner | M | - |
Ruprecht-Karls-Universität Heidelberg
| 3 years |
| Lothar H. Finke | M | - | 9 years | |
| Oliver Clasen | M | 60 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 5 years |
| David S. McCullough | M | 59 | 5 years | |
| Irwin Scher | M | 84 | 3 years | |
| Norbert Riedel | M | 66 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 3 years |
| Cory Gossard | M | 50 |
Ruprecht-Karls-Universität Heidelberg
| 4 years |
| Jon Stonehouse | M | 63 | 4 years | |
| Edgar Löffler | M | 71 |
Ruprecht-Karls-Universität Heidelberg
| 2 years |
| Karl Nägler | M | - |
Horizon Therapeutics Switzerland GmbH
Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | - |
| Uwe Hans Reuter | M | 69 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 3 years |
| Wolfgang Pietzsch | M | - |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 6 years |
| Michael Becker | M | 76 | 13 years | |
| David Smoller | M | 60 | 2 years | |
| Crocifissa Attardo | F | 62 | 23 years | |
| Gregor Asshoff | M | 60 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 5 years |
| Markus Schneider | M | - |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 4 years |
| Hubertus Ludwig | M | - |
Horizon Therapeutics Switzerland GmbH
Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | - |
| Hans Fünfschilling | M | - |
Horizon Therapeutics Switzerland GmbH
Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | - |
| Stefan Rupp | M | - | - | |
| Robert Diepold | M | 67 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 3 years |
| Dieter Glüder | M | 69 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 3 years |
| Daniel L. Menichella | M | 64 | 5 years | |
| Elke Eller | M | 62 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 5 years |
| Titus Weinheimer | M | 58 |
Ruprecht-Karls-Universität Heidelberg
| 4 years |
| Bernhard R. M. Ehmer | M | 69 | 8 years | |
| Martin Bürmann | M | 55 |
Ruprecht-Karls-Universität Heidelberg
| 5 years |
| Iris Löw-Friedrich | M | 63 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 3 years |
| Andreas Busch | M | 59 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
| 3 years |
| Andrea Buscaglia | M | 60 |
Horizon Therapeutics Switzerland GmbH
Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | 2 years |
| Dorothea Wenzel | M | 55 | 17 years | |
| Karsten Bahlmann | M | - |
Ruprecht-Karls-Universität Heidelberg
| 6 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Germany | 89 | 89.90% |
| Switzerland | 10 | 10.10% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Achim Schäffler
- Personal Network
